Vanuatu vs Zimbabwe: Hepatitis B surface antigen (HBsAg) prevalence
Vanuatu
1.8%
in 2024
Zimbabwe
1.8%
in 2024
Vanuatu rank
13th
Zimbabwe rank
13th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Vanuatu
- Zimbabwe
How they compare
Vanuatu currently reports 1.8% against 1.8% in Zimbabwe, a difference of 0.0%.
Across all 10 years both countries report, Zimbabwe has been ahead every year.
Vanuatu ranks 13th and Zimbabwe ranks 13th of 194 countries.
Zimbabwe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Vanuatu | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.6% | 2.0% | 0.3% | Zimbabwe |
| 2020s | 1.7% | 2.0% | 0.3% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Vanuatu or Zimbabwe?
- Vanuatu, at 1.8% against 1.8% in Zimbabwe as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Vanuatu and Zimbabwe?
- 0.0%, with Vanuatu ahead.
- How many years of comparable data are there for Vanuatu and Zimbabwe?
- 10 years are reported by both, from 2015 to 2024.
- How do Vanuatu and Zimbabwe rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Vanuatu ranks 13th and Zimbabwe ranks 13th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.